Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology.
Lancet Oncol
; 19(5): e240-e251, 2018 05.
Article
in En
| MEDLINE
| ID: mdl-29726389
Full text:
1
Database:
MEDLINE
Main subject:
Radiation Oncology
/
Precision Medicine
/
Molecular Targeted Therapy
/
Chemoradiotherapy
/
Immunologic Factors
/
Immunotherapy
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Guideline
/
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Lancet Oncol
Journal subject:
NEOPLASIAS
Year:
2018
Type:
Article